Author:
Kannavou Maria,Natsaridis Evangelos,Missirlis Athanassios
Reference107 articles.
1. Liposomal drug delivery to the lungs: a post covid-19 scenario;Krishna;J Liposome Res,2023
2. Overcoming barriers by local drug delivery with liposomes;Antimisiaris;Adv Drug Deliv Rev,2021
3. Inhaled liposomal antimicrobial delivery in lung infections;Bassetti;Drugs,2020
4. Nanotechnology-assisted metered-dose inhalers (MDIs) for high-performance pulmonary drug delivery applications;Kumar;Pharmaceut Res,2022
5. Inhalable liposomes for treating lung diseases: clinical development and challenges;Ponkshe;Biomed Mater (Bristol),2021